MRGPRX4 and Pruritus: In addition, certain drugs such as nateglinide, a potassium ATP channel blocker used for treatment of type 2 diabetes, are hypothesized to cause pruritus and urticarial rash by activating MRGPRX4 as an off-target side effect (4, 10).